10.0.3.114

Cempra Pharmaceuticals raises $46m in venture funding to combat drug-resistant infections

By
-
281
The funds will be used for the continued clinical development of CEM-101, Cempra’s lead macrolide compound; CEM-102, i

RELATED ARTICLESMORE FROM AUTHOR